Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Reichman

Showing results (241-250 of 301) with videos related to

Pageof 31
Sort By:
Vaccine|June 2, 1998
Placental transfer of maternal poliovirus antibodies in full-term and pre-term infantsN Linder, I Taushtein, R Handsher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinomaB Reichman, M Markman, T Hakes, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 6, 2005
Smoking and tuberculosis: the epidemiological association and immunopathogenesisP D O Davies, W W Yew, D Ganguly, et al.
Journal of Cancer Research and Clinical Oncology|January 11, 1992
Salvage intraperitoneal therapy of small-volume residual ovarian cancer: impact of pretreatment finding of peritoneal carcinomatosis on the surgical complete response rateM Markman, B Reichman, T Hakes, et al.
Cancer|February 15, 1993
Phase II trial of carboplatin and etoposide in metastatic breast cancerJ Crown, T Hakes, B Reichman, et al.
Gynecologic Oncology|May 1, 1993
The use of recombinant human erythropoietin to prevent carboplatin-induced anemiaM Markman, B Reichman, T Hakes, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1993
Intraperitoneal administration of Taxol in the management of ovarian cancerM Markman, E Rowinsky, T Hakes, et al.
Gynecologic Oncology|July 1, 1993
Mitomycin-C plus a 3-day continuous intravenous infusion of 5-fluorouracil: an inactive salvage regimen for platinum-resistant ovarian carcinomaB Reichman, M Markman, T Hakes, et al.
Gynecologic Oncology|February 1, 1993
Evidence for persistence of mitoxantrone within the peritoneal cavity following intraperitoneal deliveryM Markman, D Alberts, S Rubin, et al.
Gynecologic Oncology|May 1, 1993
Impact of age on survival of patients with ovarian cancerM Markman, J L Lewis, P Saigo, et al.
Pageof 31

Showing results (241-250 of 301) with videos related to

Sort By:
Pageof 31
Vaccine|June 2, 1998
Placental transfer of maternal poliovirus antibodies in full-term and pre-term infantsN Linder, I Taushtein, R Handsher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinomaB Reichman, M Markman, T Hakes, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 6, 2005
Smoking and tuberculosis: the epidemiological association and immunopathogenesisP D O Davies, W W Yew, D Ganguly, et al.
Journal of Cancer Research and Clinical Oncology|January 11, 1992
Salvage intraperitoneal therapy of small-volume residual ovarian cancer: impact of pretreatment finding of peritoneal carcinomatosis on the surgical complete response rateM Markman, B Reichman, T Hakes, et al.
Cancer|February 15, 1993
Phase II trial of carboplatin and etoposide in metastatic breast cancerJ Crown, T Hakes, B Reichman, et al.
Gynecologic Oncology|May 1, 1993
The use of recombinant human erythropoietin to prevent carboplatin-induced anemiaM Markman, B Reichman, T Hakes, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1993
Intraperitoneal administration of Taxol in the management of ovarian cancerM Markman, E Rowinsky, T Hakes, et al.
Gynecologic Oncology|July 1, 1993
Mitomycin-C plus a 3-day continuous intravenous infusion of 5-fluorouracil: an inactive salvage regimen for platinum-resistant ovarian carcinomaB Reichman, M Markman, T Hakes, et al.
Gynecologic Oncology|February 1, 1993
Evidence for persistence of mitoxantrone within the peritoneal cavity following intraperitoneal deliveryM Markman, D Alberts, S Rubin, et al.
Gynecologic Oncology|May 1, 1993
Impact of age on survival of patients with ovarian cancerM Markman, J L Lewis, P Saigo, et al.
Pageof 31